On Invalid Date, Biotricity (NASDAQ: BTCY) reported Q4 2023 earnings per share (EPS) of -$0.34, up 37.91% year over year. Total Biotricity earnings for the quarter were -$3.05 million. In the same quarter last year, Biotricity's earnings per share (EPS) was -$0.55.
As of Q1 2024, Biotricity's earnings has grown year over year. Biotricity's earnings in the past year totalled -$15.39 million.
What was BTCY's revenue last quarter?
On Invalid Date, Biotricity (NASDAQ: BTCY) reported Q4 2023 revenue of $2.97 million up 20.89% year over year. In the same quarter last year, Biotricity's revenue was $2.46 million.
What was BTCY's revenue growth in the past year?
As of Q1 2024, Biotricity's revenue has grown 28.55% year over year. This is 19.45 percentage points higher than the US Medical Devices industry revenue growth rate of 9.1%. Biotricity's revenue in the past year totalled $11.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.